Amarin reported $-13073000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Aerie Pharmaceuticals AERI:US $ -32.37M 0.87M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amarin AMRN:US $ -13.07M 21.85M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
AstraZeneca AZN:LN -1674000000 2.8B
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Epizyme EPZM:US $ -64140000 5.91M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
GlaxoSmithKline GSK:LN 1.94B 263M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
IONIS PHARMACEUT IONS:US $ -86M 4.4M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NOVN:VX 3.23B 246M
Teva Pharmaceutical Industries TEVA:US $ 623M 41M